scispace - formally typeset
B

Bruce L. Miller

Researcher at University of California, San Francisco

Publications -  1296
Citations -  135366

Bruce L. Miller is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Frontotemporal dementia & Dementia. The author has an hindex of 163, co-authored 1153 publications receiving 115975 citations. Previous affiliations of Bruce L. Miller include University of Southern California & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Patterns of Cerebral Hypoperfusion in Amnestic and Dysexecutive MCI

TL;DR: The finding that single-domain MCI patients with prominent deficits in different cognitive domains exhibited different patterns of hypoperfusion relative to controls supports the existence of distinct subgroups of MCI and suggests that cognitive impairment in MCI is related to cerebral hypoperFusion.
Journal ArticleDOI

Diagnosis and Management of Behavioral Variant Frontotemporal Dementia

TL;DR: Recognizing the various presentations of bvFTD and its histological and genetic subtypes might further diagnosis, treatment, and research, and suggest that functional networks are diminished that might be relevant to empathy and social behavior.
Journal ArticleDOI

What role does the anterior temporal lobe play in sentence-level processing? neural correlates of syntactic processing in semantic variant primary progressive aphasia

TL;DR: The findings indicate that spared syntactic processing in semantic PPA depends on preserved functionality of structurally intact left frontal regions and moderately atrophic left posterior temporal regions, but no functional reorganization was apparent as a consequence of anterior temporal atrophy and dysfunction.
Journal ArticleDOI

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

Cyril Pottier, +145 more
- 01 Jun 2018 - 
TL;DR: In this paper, a meta-analysis was conducted to identify potential genetic modifiers of disease onset and disease risk in frontotemporal lobar degeneration (FTLD) carriers.